Hemagglutinin-Esterase Cannot Be Considered As a Candidate for Designing Drug Against Covid-19

Hemagglutinin-Esterase Cannot Be Considered As a Candidate for Designing Drug Against Covid-19 Publisher Pubmed

Zandi M^{1, 2} ; Soltani S^{1, 2}

Source: Molecular Diversity Published:2021

Abstract

We read with interest the article by Patel et al. on the identification of potential inhibitors of coronavirus hemagglutinin-esterase. The authors considered hemagglutinin-esterase as a glycoprotein of SARS-CoV-2 and selected hemagglutinin-esterase as a target to identify potential inhibitors using a combination of various computational approaches, and however, SARS-CoV-2 genome lacks hemagglutinin-esterase gene; thus, hemagglutinin-esterase does not exist in SARS-CoV-2 particle. Graphic abstract: [Figure not available: see fulltext.]. © 2021, The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Related Docs

View other Related Docs

1. Overview of the Current Promising Approaches for the Development of an Effective Severe Acute Respiratory Syndrome Coronavirus 2 (Sars-Cov-2) Vaccine, International Immunopharmacology (2020)

2. Target Genes Used for Biosensor Development in Covid-19 Diagnosis, Biosensors and Bioelectronics (2022)

3. Rational Approaches to Discover Sars-Cov-2/Ace2 Interaction Inhibitors: Pharmacophore-Based Virtual Screening, Molecular Docking, Molecular Dynamics and Binding Free Energy Studies, Journal of Molecular Liquids (2023)

Experts (# of related papers)

View all Related Experts

Nima Rezaei (2)

Mohsen Ghadami (1)

Style	Citing Format
MLA	Zandi M, Soltani S. "Hemagglutinin-Esterase Cannot Be Considered As a Candidate for Designing Drug Against Covid-19." Molecular Diversity, vol. 25, no. 3, 2021, pp. 1999-2000.
APA	Zandi M, Soltani S (2021). Hemagglutinin-Esterase Cannot Be Considered As a Candidate for Designing Drug Against Covid-19. Molecular Diversity, 25(3), 1999-2000.
Chicago	Zandi M, Soltani S. "Hemagglutinin-Esterase Cannot Be Considered As a Candidate for Designing Drug Against Covid-19." Molecular Diversity 25, no. 3 (2021): 1999-2000.
Harvard	Zandi M, Soltani S (2021) 'Hemagglutinin-Esterase Cannot Be Considered As a Candidate for Designing Drug Against Covid-19', Molecular Diversity, 25(3), pp. 1999-2000.
Vancouver	Zandi M, Soltani S. Hemagglutinin-Esterase Cannot Be Considered As a Candidate for Designing Drug Against Covid-19. Molecular Diversity. 2021;25(3):1999-2000.
BibTex	@article{ author = {Zandi M and Soltani S}, title = {Hemagglutinin-Esterase Cannot Be Considered As a Candidate for Designing Drug Against Covid-19}, journal = {Molecular Diversity}, volume = {25}, number = {3}, pages = {1999-2000}, year = {2021} }
RIS	TY - JOUR AU - Zandi M AU - Soltani S TI - Hemagglutinin-Esterase Cannot Be Considered As a Candidate for Designing Drug Against Covid-19 JO - Molecular Diversity VL - 25 IS - 3 SP - 1999 EP - 2000 PY - 2021 ER -

Science Communicator Platform

Authors

Abstract